[Recent development of calcitonin gene-related peptide (CGRP) receptor antagonist].
Kojima
Shu-ichi
S
Department of Pharmacology, Dokkyo University School of Medicine.
Kamikawa
Yuichiro
Y
D000818:Animals; D000077221:Calcitonin Gene-Related Peptide Receptor Antagonists; D015195:Drug Design; D006801:Humans; D043183:Irritable Bowel Syndrome / Q000188:drug therapy / Q000209:etiology; D008881:Migraine Disorders / Q000188:drug therapy / Q000209:etiology; D010879:Piperazines / Q000494:pharmacology / Q000627:therapeutic use; D011799:Quinazolines / Q000494:pharmacology / Q000627:therapeutic use; D018015:Receptors, Calcitonin Gene-Related Peptide / Q000145:classification / Q000502:physiology; D009435:Synaptic Transmission / Q000187:drug effects; D014664:Vasodilation / Q000187:drug effects
D000077221:Calcitonin Gene-Related Peptide Receptor Antagonists; D010879:Piperazines; D011799:Quinazolines; D018015:Receptors, Calcitonin Gene-Related Peptide; C406305:olcegepant